 Connection
Jane Reusch to Aged, 80 and over
This is a "connection" page, showing publications Jane Reusch has written about Aged, 80 and over.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.039 |
|
|
|
-
Erlandson KM, Gustafson L, Johnson JE, Kulik GL, Khuu V, Chahal N, Walpert AR, Galdamez ME, Zorgno I, Foldyna B, Jarraya M, Reusch JE, Lee H, Grinspoon SK, Jankowski CM, Fourman LT. Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol. BMJ Open. 2026 Jul 08; 16(7):e120740.
Score: 0.025
-
Pratley RE, Reusch JE, Fleck PR, Wilson CA, Mekki Q. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Curr Med Res Opin. 2009 Oct; 25(10):2361-71.
Score: 0.008
-
Bergenstal RM, Nag SS, Reusch JE, Sajjan SG, Alexander CM. Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control. Endocr Pract. 2005 May-Jun; 11(3):172-9.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|